ELISpot and Fluorospot Assay Market Set to Reach USD 528.30 Million by 2032, Driven by Immuno-Oncology Research and Diagnostic Innovation
Austin, June 18, 2025 (GLOBE NEWSWIRE) -- ELISpot and Fluorospot Assay Market Size & Growth Analysis:
According to SNS Insider, the global ELISpot and Fluorospot Assay Market was valued at USD 290.92 million in 2023 and is projected to reach USD 528.30 million by 2032, growing at a CAGR of 6.85% during the forecast period of 2024–2032. The U.S. market alone was valued at USD 79.68 million in 2023, forecasted to climb to USD 138.33 million by 2032, with a CAGR of 6.32%.Get a Sample Report of ELISpot and Fluorospot Assay Market@ https://www.snsinsider.com/sample-request/5790
The growth trajectory is largely fueled by increasing applications in infectious disease diagnostics, cancer immunotherapy, and autoimmune disease research. As demand for highly sensitive immune response assays grows, these platforms are rapidly being adopted by hospitals, biotech firms, and academic labs.
Market Overview
The ELISpot and Fluorospot assays are gaining traction across immunological research and clinical diagnostics due to their precision in detecting immune responses. Widely utilized in vaccine development, autoimmune disease studies, and cancer immunotherapy, these assays are supported by the increasing demand for high-sensitivity diagnostics.
The U.S. remains a key contributor to market growth, benefiting from strong research funding, a highly developed healthcare infrastructure, and the presence of major industry players. Globally, market expansion is further driven by the rising incidence of chronic and infectious diseases and the growing adoption of personalized medicine. Technological advancements in assay analyzers and kits are expected to fuel additional market momentum throughout the forecast period.
Major Players Analysis Listed in this Report are:
Becton, Dickinson, and Company (BD ELISPOT Assay System, BD FluoroSpot Assay Kit)
U-CyTech biosciences (Human IFN-γ ELISPOT Kit, Monkey IL-4 FluoroSpot Kit)
Cellular Technologies Limited (CTL) (ImmunoSpot Human IFN-γ ELISPOT Kit, ImmunoSpot Human IL-2/IL-4 FluoroSpot Kit)
Mabtech AB (Human IFN-γ ELISpotPRO Kit, Human IL-2/IL-4 FluoroSpot Kit)
Abcam (Human IFN-γ ELISPOT Kit, Human IL-17A/IL-22 FluoroSpot Kit)
Oxford Immunotec (T-SPOT.TB Test, T-SPOT.COVID Test)
Bio-Techne Corporation (Human IFN-γ ELISpot Kit, Human IL-10/IL-12 FluoroSpot Kit)
Autoimmun Diagnostika GmbH (AID) (AID iSpot ELISPOT Plate Reader, AID iSpot Spectrum FluoroSpot Reader)
Lophius Biosciences GmbH (T-Track ELISPOT Kit, T-Track CMV FluoroSpot Kit)
Bio-Connect B.V. (Human TNF-α ELISPOT Kit, Human IL-5/IL-13 FluoroSpot Kit)
Thermo Fisher Scientific (Mabtech Human IFN-γ ELISpot Kit, Mabtech Human IL-2/IL-4 FluoroSpot Kit)
PerkinElmer Inc. (ATPlite Luminescence Assay System, LANCE Ultra TR-FRET Assay)
R&D Systems (Human IFN-γ ELISPOT Kit, Human IL-17/IL-22 FluoroSpot Kit)
Enzo Life Sciences (Human IFN-γ ELISPOT Kit, Human IL-4/IL-5 FluoroSpot Kit)
MilliporeSigma (Merck KGaA) (ELISpot Plate Reader System, FluoroSpot Multi-Analyte Assay Kit)
ImmunoDiagnostics Limited (Human IFN-γ ELISPOT Kit, Human IL-21/IL-22 FluoroSpot Kit)
ALPCO (Human IFN-γ ELISPOT Kit, Human IL-10/IL-12 FluoroSpot Kit)
RayBiotech Life, Inc. (Human IFN-γ ELISPOT Kit, Human IL-6/IL-8 FluoroSpot Kit)
Cell Sciences (Human IFN-γ ELISPOT Kit, Human IL-2/IL-5 FluoroSpot Kit)
ZellBio GmbH (Human IFN-γ ELISPOT Kit, Human IL-4/IL-10 FluoroSpot Kit)
ELISpot and Fluorospot Assay Market Report Scope
Report Attributes
Details
Market Size in 2023
USD 290.92 million
Market Size by 2032
USD 528.30 million
CAGR (2024–2032)
6.85%
U.S. Market 2023
USD 79.68 million
U.S. Forecast by 2032
USD 138.33 million
Base Year
2023
Forecast Period
2024–2032
Key Regional Coverage
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Segment Analysis
By Product
The assay kits segment captured the highest market share of 48.56% in 2023. This is due to the extensive use of assay kits in research and diagnostic applications. The need for high-sensitivity detection in immunological studies also contributes to the growth of this segment.
The segment of analyzers will be growing at the highest rate. The high demand for automated and high-throughput analyzers in research and laboratory settings is driving the growth of this segment. These analyzers improve accuracy and efficiency, leading to increasing demand in the market.
By Application
The diagnostic applications market held 65.41% of the market share in 2023. The growing incidence of infectious diseases, autoimmune diseases, and cancer has driven the demand for ELISpot and Fluorospot assays in clinical diagnostics. These assays provide accurate and early detection, leading to their popularity in diagnostic laboratories and healthcare facilities.
The research applications segment is expected to witness the most rapid growth. The growing emphasis on immunological research, vaccine discovery, and T-cell monitoring in cancer and infectious disease research is propelling the growth of this segment. Growing funding and advances in technology are also driving its rapid growth.
By End Use
The hospitals and clinical laboratories segment accounted for the largest share of 47.25% in 2023. The rising need for sophisticated diagnostic equipment in healthcare facilities, as well as the rising number of hospital-based research studies, has supported the application of ELISpot and Fluorospot assays in hospitals and clinical labs.
The biopharmaceutical and research institutes segment is expected to grow at the fastest rate. The growing investment in drug discovery and immunological research by academic institutions and pharmaceutical companies is fueling the demand for these assays in research settings.
For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/5790
ELISpot and Fluorospot Assay Market Segmentation
By Product
Assay Kits
Analyzers
Ancillary Products
By Application
Research Applications
Diagnostics Applications
By End Use
Hospital and Clinical Labs
Academic and Research Institutes
Biopharmaceutical Company
Regional Insights
North America dominated the worldwide market in 2023 with a share of 36.25%, driven by its well-developed healthcare infrastructure, robust research culture, and high prevalence of adoption of next-generation diagnostic technologies. The United States is particularly prominent because of high government and private investment in immunology and infectious disease research.
The Asia-Pacific market is expected to have the highest growth rate until 2032. The major drivers include the growth of healthcare infrastructure, higher R&D spending, and an increasing prevalence of infectious diseases.
Recent Developments
February 2025: BD announced the separation of its Biosciences and Diagnostic Solutions business to enhance strategic focus and growth, potentially impacting its immunoassay product offerings, including ELISpot and Fluorospot assays.
April 2024: U-CyTech Biosciences was recognized as a leading company in the ELISpot and Fluorospot assay market, significantly contributing to immunological research and clinical diagnostics.
February 2024: Cellular Technology Limited (CTL) was identified as a major player in the ELISpot and Fluorospot assay market, with substantial contributions to assay development and distribution.
Statistical Insights and Trends Reporting
The United States accounted for approximately 40% of the global market share in 2023, driven by extensive research funding and strong healthcare infrastructure.
The total number of ELISpot and Fluorospot assay kits and analyzers deployed worldwide is expected to increase by 70% between 2024 and 2032.
The spending on immunology-based diagnostics, including ELISpot and Fluorospot assays, increased by 9.5% in 2023, reflecting the growing focus on early disease detection.
The use of ELISpot and Fluorospot assays in immuno-oncology research is expected to grow by 85% by 2032, driven by increasing interest in personalized medicine and T-cell monitoring.
Buy a Single-User PDF of ELISpot and Fluorospot Assay Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5790
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Immune-related Diseases (2023)
5.2 Research and Clinical Adoption Trends, by Region (2023)
5.3 Assay Kit and Analyzer Volume, by Region (2020-2032)
5.4 Assay Kit and Analyzer Volume, by Region (2020-2032)
6. Competitive Landscape
7. ELISpot and Fluorospot Assay Market by Product
8. ELISpot and Fluorospot Assay Market by Application
9. ELISpot and Fluorospot Assay Market by End Use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
North America Leads Adoption; Asia-Pacific Emerges as Key Growth Region
The Connected Logistics Market is projected to surge from USD 26.1 billion in 2025 to USD 80.4 billion by 2034, growing at a 13.3% CAGR. Driven by e-commerce, IoT adoption, and demand for efficiency, the market benefits from real-time data and AI-powered solutions. Major growth regions include North America, Europe, and Asia-Pacific. Connected Logistics Market Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Connected Logistics Market 2025-2034" report has been added to Logistics Market is valued at USD 26.1 billion in 2025. Further the market is expected to grow by a CAGR of 13.3% to reach global sales of USD 80.4 billion in 2034The connected logistics market is experiencing significant growth as businesses increasingly prioritize efficiency, transparency, and real-time data in their supply chain operations. Connected logistics involves the use of IoT sensors, RFID tags, GPS trackers, and advanced data analytics to monitor and manage the movement of goods. By leveraging these technologies, companies can optimize routes, improve inventory management, enhance delivery accuracy, and respond more quickly to unexpected drivers for this market include the rise of e-commerce, growing consumer expectations for fast and reliable delivery, and the need for greater supply chain visibility. Connected logistics solutions allow businesses to track shipments in real-time, identify bottlenecks, and proactively address issues before they escalate. In addition, advancements in artificial intelligence and machine learning are enabling predictive analytics, helping companies forecast demand, anticipate maintenance needs, and optimize warehouse North America and Europe are leading the connected logistics market due to their well-established logistics infrastructure, high adoption of IoT technologies, and strong focus on innovation. Meanwhile, Asia-Pacific is emerging as a key growth region, driven by rapid industrialization, expanding e-commerce activity, and increasing investments in smart supply chain solutions. With continuous technological advancements and a global push for more efficient supply chain operations, the connected logistics market is poised for sustained Insights Connected Logistics Market Growing integration of IoT-enabled sensors and devices for real-time shipment tracking and condition monitoring. Expansion of cloud-based logistics platforms to facilitate data sharing and collaboration across supply chains. Increased adoption of AI-driven analytics to optimize routes, inventory levels, and delivery times. Development of blockchain solutions for enhanced transparency and security in supply chain transactions. Rising interest in green logistics solutions that leverage connected technologies to reduce emissions and improve energy efficiency. Rising consumer demand for faster, more reliable delivery services. Growing e-commerce activity driving the need for real-time inventory and shipment tracking. Advancements in IoT, big data, and AI enabling smarter logistics operations. Increased focus on supply chain visibility to mitigate risks and reduce operational costs. High initial investment costs for connected logistics infrastructure. Data security and privacy concerns related to the use of IoT devices and cloud platforms. Fragmentation of the logistics ecosystem, creating integration and interoperability challenges. Your Takeaways From this Report Global Connected Logistics market size and growth projections (CAGR), 2024-2034 Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Connected Logistics. Connected Logistics market size, share, and outlook across 5 regions and 27 countries, 2025-2034. Connected Logistics market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025-2034. Short and long-term Connected Logistics market trends, drivers, restraints, and opportunities. Porter's Five Forces analysis, Technological developments in the Connected Logistics market, Connected Logistics supply chain analysis. Connected Logistics trade analysis, Connected Logistics market price analysis, Connected Logistics Value Chain Analysis. Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products. Latest Connected Logistics market news and developments. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $26.1 Billion Forecasted Market Value (USD) by 2034 $80.4 Billion Compound Annual Growth Rate 13.3% Regions Covered Global Companies Featured Microsoft Corporation AT&T Inc DHL International GmbH Robert Bosch GmbH FedEx Corporation Huawei Technologies Amazon Web Services Siemens Intel Corporation Accenture International Business Machines Corporation Cisco System Inc. Oracle Corporation Honeywell International Inc. SAP SE TATA Consulting Services Ltd NEC Corporation Nippon Express Co. Ltd. Infosys Limited HCL Technology Limited Xpo Logistics Inc. Hexagon AB Senko Group Holdings Co. Ltd Yusen Logistics Co. Ltd. Trimble Orbcomm Eurotech Group Freightgate Inc Connected Logistics Market Segmentation By Component Solutions Services By Transportation Railways Airways Maritime By Application Optimized Warehousing Real-Time Fleet Management Predictive Maintenance Cargo Integrity Monitoring End-To-End Delivery Tracking Other Applications By End-Use Industries Healthcare And Pharmaceuticals Oil And Gas Food And Beverage Aerospace And Defense Manufacturing Information Technology (IT) And Telecommunication Retail And E-Commerce Other End-Use Industries By Geography North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Connected Logistics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences
The agricultural biotechnology market presents opportunities in gene editing, precision breeding, and AI integration, driven by demand for climate-resilient, sustainable solutions. Regional innovation and strategic alliances are key, with expanding applications in pharma, biofuels, and industry enhancing growth potential. Agricultural Biotechnology Market Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Agricultural Biotechnology Market by Crop Type, Trait Type, Application, Technology, End Use - Global Forecast to 2030" report has been added to offering. The agricultural biotechnology market is navigating a critical era of innovation, with advancements in gene editing, precision breeding, and data-driven agronomy setting new standards for industry growth. Decision-makers face elevated expectations for resilient, efficient solutions amid regulatory shifts, evolving trade dynamics, and increasing focus on sustainability. Agricultural Biotechnology Market Overview The agricultural biotechnology market grew from USD 58.47 billion in 2024 to USD 65.60 billion in 2025 and is forecast to reach USD 113.24 billion by 2030, demonstrating a CAGR of 11.64%. This robust expansion is driven by demand for enhanced crop yield, resilience to changing climate conditions, and the adoption of sophisticated biotechnological tools across key global regions. Growing attention to food security, regional innovation initiatives, and regulatory progress underpin this upward trajectory. Scope & Segmentation This market research delivers a comprehensive analysis, structuring the agricultural biotechnology landscape around vital segments, technology platforms, and regional activity to support actionable strategic planning: Crop Types: Cereals (barley, maize, rice, wheat), fruits and vegetables (apple, potato, tomato), oilseeds (rapeseed, soybean, sunflower), and pulses (chickpea, lentil, pea). Trait Types: Disease resistance, drought tolerance, herbicide tolerance, and insect resistance shape R&D priorities and crop performance. Application Areas: Includes biopesticides, diagnostics, micropropagation, and seeds to address diverse market and production needs. Technologies: Bioinformatics, genetic engineering, tissue culture (organogenesis and somatic embryogenesis), and molecular marker systems (SNP and SSR) accelerate breeding and trait development. End Use Segments: Applications span biofuel, fiber, food and feed, as well as pharmaceutical and industrial products, reflecting the sector's versatility. Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with the United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan). Leading Companies: The market features prominent players such as Bayer Aktiengesellschaft, Corteva, Inc., Syngenta AG, BASF SE, FMC Corporation, Bioceres Crop Solutions Corp., Evogene Ltd., Marrone Bio Innovations, Inc., Calyxt, Inc., and Arcadia Biosciences, Inc. Key Takeaways for Senior Decision-Makers Gene editing technologies like CRISPR-Cas9 have significantly expedited trait development, resulting in more precise improvements in disease resistance and environmental adaptation. Artificial intelligence and remote sensing are increasingly integrated into farming operations, optimizing input use and supporting data-driven field management. Regional momentum is diverse, with the Americas fostering rapid commercialization, Europe & the Middle East driving targeted desert-adapted crops, and Asia-Pacific advancing large-scale public-private biotech initiatives. Strategic alliances are central to market leadership, as companies expand innovation portfolios and enter collaborations to access emerging market opportunities and next-generation agritech platforms. Growing attention to sustainability, regulatory adaptation, and public acceptance is influencing product development and competitive positioning. Expanding applications into pharmaceutical, biofuel, and industrial domains provide additional pathways for value creation and market resilience. Tariff Impact Reshaping Trade Flows Recent United States tariff changes have led to shifts in global trade strategies for biotech seeds and inputs. Companies are revising supply chains, investing in alternative production sites, and focusing on regions with more favorable regulatory and tariff environments. These dynamics have catalyzed the emergence of regional innovation clusters and increased the need for ongoing trade diplomacy to ensure uninterrupted market access. Why This Report Matters Enables senior leaders to anticipate market movements across technologies, regions, and applications, supporting proactive investment and planning. Delivers a clear framework for assessing regulatory, technological, and trade risks in real time. Facilitates targeted partnership cultivation and portfolio diversification aligned with the evolving agricultural biotechnology landscape. The agricultural biotechnology market is evolving through scientific, regulatory, and commercial transformations. Equipped with actionable insights, organizations are well-positioned to drive sustainable innovation and secure a competitive edge. Companies Featured The companies profiled in this Agricultural Biotechnology market report include: Bayer Aktiengesellschaft Corteva, Inc. Syngenta AG BASF SE FMC Corporation Bioceres Crop Solutions Corp. Evogene Ltd. Marrone Bio Innovations, Inc. Calyxt, Inc. Arcadia Biosciences, Inc. Key Attributes: Report Attribute Details No. of Pages 183 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $65.6 Billion Forecasted Market Value (USD) by 2030 $113.24 Billion Compound Annual Growth Rate 11.6% Regions Covered Global Key Topics Covered: 1. Preface2. Research Methodology3. Executive Summary4. Market Overview4.1. Introduction4.2. Market Sizing & Forecasting5. Market Dynamics6. Market Insights6.1. Porter's Five Forces Analysis6.2. PESTLE Analysis7. Cumulative Impact of United States Tariffs 20258. Agricultural Biotechnology Market, by Crop Type8.1. Introduction8.2. Cereals8.2.1. Barley8.2.2. Maize8.2.3. Rice8.2.4. Wheat8.3. Fruits And Vegetables8.3.1. Apple8.3.2. Potato8.3.3. Tomato8.4. Oilseeds8.4.1. Rapeseed8.4.2. Soybean8.4.3. Sunflower8.5. Pulses8.5.1. Chickpea8.5.2. Lentil8.5.3. Pea9. Agricultural Biotechnology Market, by Trait Type9.1. Introduction9.2. Disease Resistant9.3. Drought Tolerant9.4. Herbicide Tolerant9.5. Insect Resistant10. Agricultural Biotechnology Market, by Application10.1. Introduction10.2. Biopesticides10.3. Diagnostics10.4. Micropropagation10.5. Seeds11. Agricultural Biotechnology Market, by Technology11.1. Introduction11.2. Bioinformatics11.3. Genetic Engineering11.4. Molecular Markers11.4.1. SNP11.4.2. SSR11.5. Tissue Culture11.5.1. Organogenesis11.5.2. Somatic Embryogenesis12. Agricultural Biotechnology Market, by End Use12.1. Introduction12.2. Biofuel12.3. Fiber12.4. Food And Feed12.5. Pharmaceutical And Industrial Products13. Americas Agricultural Biotechnology Market13.1. Introduction13.2. United States13.3. Canada13.4. Mexico13.5. Brazil13.6. Argentina14. Europe, Middle East & Africa Agricultural Biotechnology Market15. Asia-Pacific Agricultural Biotechnology Market16. Competitive Landscape16.1. Market Share Analysis, 202416.2. FPNV Positioning Matrix, 202416.3. Competitive Analysis16.3.1. Bayer Aktiengesellschaft16.3.2. Corteva, Inc.16.3.3. Syngenta AG16.3.4. BASF SE16.3.5. FMC Corporation16.3.6. Bioceres Crop Solutions Corp.16.3.7. Evogene Ltd.16.3.8. Marrone Bio Innovations, Inc.16.3.9. Calyxt, Inc.16.3.10. Arcadia Biosciences, more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Agricultural Biotechnology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
38 minutes ago
- Business Wire
AM Best Affirms Credit Ratings of Trisura Group Ltd. Members
OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of 'a-' (Excellent) of Trisura Specialty Insurance Company (TSIC), Trisura Insurance Company (TIC), Bricktown Specialty Insurance Company (BSIC) and Trisura Guarantee Insurance Company (TGIC). Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of 'a-' (Excellent) of First Founders Assurance Company (FFAC) (Chester, NJ). The aforementioned companies are subsidiaries of Trisura Group Ltd. (TGL) [TSX: TSU] (Toronto, Ontario, Canada), a non-operating holding company. TSIC, TIC, and BSIC are domiciled in Oklahoma City, OK, while TGIC is domiciled in Toronto, Ontario, Canada. The outlook of these Credit Ratings (ratings) is stable. The ratings reflect TGL's overall balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM). The ratings acknowledge improvement in TGL's overall balance sheet strength assessment, supported by the strongest level of risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio (BCAR). Additionally, the group's capital base has grown significantly over the recent five-year period, driven by several public capital raises and very strong earnings growth, which more than tripled in the recent three-year period. This growth in equity has supported the group's overall growth and its expansion into the admitted U.S. market. While underwriting leverage was previously elevated due to an accelerated growth period, recent moderation in premium growth, combined with capital expansion, has resulted in leverage metrics that closely align with industry norms. Financial flexibility is strong with moderate levels of debt and very strong interest coverage. TGL's operating performance benefits from the diversification in its earnings from fronting fee income, underwriting income and investment income and its business profile recognizes the diversification afforded by its diversified North American footprint, providing specialty insurance in the surety, warranty, corporate insurance, program and fronting business lines. The ratings of FFAC reflect its balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate ERM. The ratings acknowledge the significant capital and operational support FFAC receives from TGL and its strategic importance to TGL's U.S. surety operations. In the second quarter of 2024, TGL contributed approximately USD $55 million of capital to FFAC. Furthermore, TGL seeks to continue to expand FFAC's licensing to all 50 states. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.
